Angiodynamics (ANGO) Other Non-Current Assets (2011 - 2026)
Angiodynamics (ANGO) posted Other Non-Current Assets of $9.5 million for Q2 2026, down 9.86% on a QoQ basis from $10.5 million in Q1 2026, and down 9.04% year-over-year from $10.4 million in Q2 2025.
Angiodynamics (ANGO) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Angiodynamics' Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $9.5 million for Q2 2026.
- Quarterly Other Non-Current Assets fell 9.04% year-over-year to $9.5 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $9.5 million (down 9.04% YoY) and the FY2026 annual result came in at $9.5 million, down 9.04% from the prior year.
- Other Non-Current Assets was $9.5 million for Q2 2026 at Angiodynamics, down from $10.5 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $43.7 million in Q2 2023 and bottomed at $9.5 million in Q2 2026.
- A 5-year average of $12.8 million and a median of $10.7 million in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 298.18% — and 2024, when it sank 73.96%.
- Angiodynamics' Other Non-Current Assets stood at $10.7 million in 2022, then soared by 307.13% to $43.7 million in 2023, then slumped by 76.86% to $10.1 million in 2024, then rose by 9.6% to $11.1 million in 2025, then declined by 14.54% to $9.5 million in 2026.
- Business Quant data shows ANGO's Other Non-Current Assets at $9.5 million in Q2 2026, $10.5 million in Q1 2026, and $11.1 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Angiodynamics | 558.11 Mn | 504.25 Mn | 46.77 Mn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 9.46 Mn |
| Feb 28, 2026 | 10.50 Mn |
| Nov 30, 2025 | 11.07 Mn |
| Aug 31, 2025 | 9.54 Mn |
| May 31, 2025 | 10.40 Mn |
| Feb 28, 2025 | 9.68 Mn |
| Nov 30, 2024 | 10.10 Mn |
| Aug 31, 2024 | 10.88 Mn |
| May 31, 2024 | 11.37 Mn |
| May 31, 2023 | 43.65 Mn |
| Feb 28, 2023 | 10.73 Mn |
| Nov 30, 2022 | 10.72 Mn |
| Aug 31, 2022 | 11.08 Mn |
| May 31, 2022 | 10.96 Mn |
| Feb 28, 2022 | 11.31 Mn |
| Nov 30, 2021 | 12.12 Mn |
| Aug 31, 2021 | 12.93 Mn |
| May 31, 2021 | 13.19 Mn |
| Feb 28, 2021 | 19.44 Mn |
| Nov 30, 2020 | 17.51 Mn |